Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-26

Clinical Trial Update: Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update for a Mimogen-based therapeutic Hepatitis B vaccine used with Entecavir in chronic Hepatitis B patients; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Therapeutic Hepatitis B Vaccine (Mimogen-based) with Entecavir

Snippet

Sponsor: Chongqing Jiachen Biotechnology Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2019-06-26